Micron’s Structural Shift: Multi-Year Supply Deals and HBM4 Production Fuel a $1 Trillion Market Cap Moment

Micron's shift to multi-year supply agreements with fixed pricing boosts earnings visibility, stock surges 18%, and analysts lift targets as HBM sales soar.

The memory-chip narrative has flipped. After decades defined by boom-and-bust cycles, Micron Technology is now locking in customers with three-to-five-year supply agreements that include fixed volumes and, in some cases, partly fixed pricing. UBS analyst Timothy Arcuri was the first on Wall Street to fully price in the implications, lifting his target to $1,625 from $535 — a 204% leap and the highest among 46 analysts covering the stock. The upgrade sent shares surging as much as 18% to $886.60, briefly lifting Micron’s market capitalization above the $1 trillion mark for the first time. That milestone, if sustained, would place the Boise-based company as the 11th-largest US-listed corporation, trailing Eli Lilly and ahead of Walmart.

The new contract structures are not theoretical. CEO Sanjay Mehrotra confirmed that Micron has already signed its first strategic five-year pact, and a “significant portion” of its DDR volume is now committed at prices slightly below spot levels. The shift provides rare earnings visibility in a sector long ruled by spot-market volatility. Arcuri projects Micron will generate over $100 in earnings per share annually from 2027 through 2029, with cumulative free cash flow exceeding $400 billion — figures that would have been unthinkable during the last downturn. On the product side, the company has begun shipping HBM4 chips in volume for Nvidia applications, and its entire High-Bandwidth Memory capacity for 2026 is already sold out. Management expects supply tightness to persist beyond next year.

The financial results backing the re-rating are equally dramatic. For its second fiscal quarter ending February 26, Micron reported revenue of $23.86 billion, nearly tripling the $8.05 billion posted in the prior-year period. GAAP gross margin surged to 74.4% from 36.8%, while adjusted net profit swelled from $1.58 billion to $13.79 billion. Adjusted earnings per share came in at $12.20. The current quarter’s guidance — revenue of $33.5 billion (plus or minus $750 million) and gross margin around 81% — implies that the profitability boom has further to run. Adjusted EPS is forecast at $19.15 (plus or minus $0.40), which would mark a fourth consecutive record.

Not every analyst is reaching as high as UBS, but the upgrade wave is broad. CFRA raised its 12-month target to $900, citing stronger earnings and cash flows driven by AI demand and customer prepayments. Citigroup increased its target to $840, pointing to aggressive DRAM price increases and an extended upcycle for both DRAM and HBM through at least 2027. HSBC and Melius Research went further to $1,100, with Melius calling Micron a “bottleneck player” in the AI ecosystem that could eventually divert market capitalization from traditional software giants and parts of the Magnificent Seven.

Yet the rally has stretched valuations to levels that give skeptics ammunition. The stock trades at 35.46 times trailing earnings, well above its five-year median of 20.72. Insiders sold $54 million worth of shares over the past three months without a single purchase — a pattern that often signals caution. The stock currently changes hands at €772.80 ($829 at recent exchange rates), up 14.56% on the week and more than 174% above its 200-day moving average of €281.27. Annualized 30-day volatility stands at a towering 90.4%, and the relative strength index at 43.8 suggests the rally has room to run before becoming overbought — but only as long as execution matches guidance.

The broader market backdrop has provided additional tailwinds. US indexes hit fresh records amid optimism over US-Iran peace talks, with the S&P 500 rising 0.6% to 7,519 and the Nasdaq Composite gaining 1.2% to 26,656. The Dow Jones Industrial Average slipped 0.2% to 50,462, underscoring the tech-heavy nature of the advance. President Trump also gave Micron a public nod, praising the company for “hundreds of billions” in domestic investment. The Philadelphia Semiconductor Index has climbed in seven of the past eight weeks, and peer Marvell Technology has strung together ten consecutive weekly gains.

For all the euphoria, the core risk remains a return to supply equilibrium. When memory production eventually catches up with AI-driven demand, pricing power will fade — and with it, the premium multiples that now underpin Micron’s valuation. The multi-year contracts provide a cushion, but they cannot insulate the company indefinitely from market forces. Until then, the UBS upgrade has handed Micron its most powerful single-day catalyst of 2026, and the debate has shifted from “is the cycle turning?” to “how long can the scarcity last?”